MIKHAEL LOOTS: Open Payments
NPI 1639128622 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 25 payments from 7 companies in 2025. Trend: 2023 $298 · 2024 $358 · 2025 $960
Food & beverage: $867Education: $93
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 19 | $373 |
| JAZZ PHARMACEUTICALS INC. | 1 | $121 |
| Eisai Inc. | 1 | $120 |
| Teleflex LLC | 1 | $118 |
| Janssen Biotech, Inc. | 1 | $109 |
| Incyte Corporation | 1 | $93 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: Enhertu, ZIIHERA, Lenvima, ARROW, RYBREVANT, DATROWAY, OPDUALAG.
Industry payments across NE — which companies pay providers there.
